ASRM Research Institute Announces New Grant Partners Program

The Howard and Georgeanna Jones Foundation, the Recurrent Pregnancy Loss Association, Ferring Pharmaceuticals, and EMD Serono, Inc. All Offer Grant Funding

Today, the American Society for Reproductive Medicine (ASRM) announced partnerships with four organizations in the reproductive health field: The Howard and Georgeanna Jones Foundation, the Recurrent Pregnancy Loss Association, Ferring Pharmaceuticals, and EMD Serono, Inc.

The Howard and Georgeanna Jones Foundation for Reproductive Medicine is funding supporting the ASRM Research Institute for a two-year research program with total grant funding of up to $50,000. The purpose of this grant is to support an innovative research project dedicated to improving assisted reproductive technology and in vitro fertilization.

The Recurrent Pregnancy Loss Association has agreed to fund an annual award of $40,000 for a two-year project. The purpose of this grant is to support innovative research that provides insights into causes, diagnosis, management, or pathogenesis of recurrent pregnancy loss.

EMD Serono, Inc. is supporting a $7,500 grant to fund a Nurse Professionals Research Award. This award, specifically supporting nursing professionals in reproductive medicine, will support research focused on clinical outcomes, including research and quality improvement projects.

In addition, EMD Serono, Inc. is awarding two educational grants to ASRM, in the amount of $15,000 each, to expand research opportunities for underrepresented minority populations in the profession and leadership of reproductive medicine, as set forth by the ASRM Task Force on Diversity, Equity, and Inclusion.

Ferring Pharmaceuticals is awarding two educational grants to ASRM, in the amount of $10,000 each, to support REI fellow-specific research in reproductive medicine. These grants will fund clinical or translational research related to the evaluation, treatment, and management of reproductive health diagnoses.

"We are pleased to announce these important opportunities and honored to be able to partner with these generous organizations. These grants represent important focus areas for us and add strength to the ASRM Research Institute, supporting the important work that is yet to be done." -- Marcelle Cedars, M.D., President of ASRM

Find out more about the ASRM Research Institute programs.

The ASRM Bulletin is published by ASRM's Office of Public Affairs to inform Society members of important recent developments. Republication or any other use of the contents of the Bulletin without permission is prohibited. To request permission to quote or excerpt material from the Bulletin, contact Sean Tipton at stipton@asrm.org.   

For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org

FAQs

FAQs

Have questions about IVF and infertility? We have answers.
Find A Clinic

Find A Clinic

National statistics from SART member clinics that reported their data through SART.